CSPC PHARMA

Forecast & Rating23 analysts currently cover CSPC PHARMA, with about 82.6% giving a positive rating — meaning they expect the stock to rise. The average price target is HK$12.31, about 34.0% upside from the current price of HK$9.19. Price targets range from HK$7.20 to HK$19.36 — a wide spread, showing clear disagreement over just how much CSPC PHARMA can rise. Historically, about 26.1% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study CSPC PHARMA closely still see room for the stock to rise. Data as of Aug 22, 2026; for reference only and not investment advice.